Anti-inflammatory compounds that target chronic inflammation pathways and support whole-body recovery.
31 itemsDo zinc lozenges shorten a cold? Research suggests properly formulated zinc lozenges may reduce duration if started early. Learn mechanisms, evidence, and cautions.
A focused look at rapamycin and the mTOR pathway in longevity: ITP mouse findings, how caloric restriction converges on mTOR, the status of human and dog trials, potential risks, and natural mTOR modulators—why the field is hopeful yet cautious.
Does post-exercise cold water immersion blunt hypertrophy? A focused review of RCTs and meta-analyses on muscle growth, strength, and recovery trade-offs.
A focused review on L‑glutamine and exercise‑induced gut permeability in athletes—mechanisms, small RCTs, immune links, and traditional bone broth context.
Animal studies suggest BPC‑157 may influence tendon and ligament healing via angiogenesis and fibroblast pathways, but no human trials confirm benefit. Not approved for medical use and prohibited by WADA.
Learn how hot water and dual extracts of medicinal mushrooms shape beta-glucans, triterpenes, and immune modulation—plus evidence on turkey tail PSK/PSP and reishi.
Are zonulin blood or stool tests accurate for “leaky gut”? This evidence-based review explains what zonulin measures, how it compares with lactulose–mannitol testing, and what research says about barrier-supportive strategies.
A focused, evidence-based look at zinc for the common cold—how it may work, what trials show, why lozenge formulation and timing matter, and key safety and balance considerations.
A focused look at how long fasting may take to engage autophagy, summarizing animal data, human intermittent fasting trials, fasting-mimicking diets, and traditional fasts—highlighting what’s known and what remains uncertain.
Does resveratrol really activate sirtuins in humans? A focused review of the evidence—French Paradox origins, bioavailability challenges, mixed trials, and how it compares to EGCG, curcumin, and quercetin.
A focused look at the NIA Interventions Testing Program’s rapamycin findings in mice, how they align with mTOR and caloric restriction biology, and what this means—cautiously—for human longevity research.
Research-backed look at whether post-workout cold exposure after strength training blunts hypertrophy and strength adaptations, with practical context.
Animal studies suggest BPC-157 may support tendon and ligament healing via angiogenesis and ECM remodeling, but robust human trials are lacking; it remains unapproved and is banned by WADA.
The updated hygiene (Old Friends) hypothesis explains how reduced microbial diversity may shape gut–immune development and influence autoimmune risk in T1D, MS, RA, and Hashimoto’s.
A focused, evidence-based look at turkey tail’s PSK and PSP extracts, how their beta-glucans may modulate immunity, and what clinical research suggests about using them as adjuncts to therapy.
Many people order serum or stool zonulin tests to assess “leaky gut.” This focused review explains what zonulin does, why assays are controversial, how results compare with validated permeability tests, and practical, evidence-informed alternatives.
Does time-restricted eating (TRE) trigger autophagy? A focused, evidence-based review of mechanisms, human trials, and how TRE compares with other fasting models.
Does cold exposure right after lifting blunt hypertrophy? Research suggests routine, immediate post-exercise cold may attenuate muscle growth, while still helping short-term recovery needs.
A focused, evidence-based review of L‑glutamine for exercise‑induced gut permeability in athletes, bridging modern research with traditional nutrition perspectives.
A focused look at how mushroom beta‑glucans engage Dectin‑1 and other receptors to modulate innate immunity, why extraction methods matter, and where human evidence stands.
Is zonulin testing a reliable way to assess intestinal permeability? This evidence-based review explains the science, assay controversies, and practical takeaways.
Can astragalus (Huang Qi) or TA-65 meaningfully support telomere health? A concise, evidence-based review of telomerase activation, human data, safety, and where traditional and modern perspectives meet.
A focused look at how caloric restriction and rapamycin converge on the mTOR pathway, what ITP mouse studies show, early human and dog trial signals, risks, and natural mTOR modulators.
A focused look at whether post‑workout cold exposure blunts muscle growth, summarizing trials, mechanisms, and where cold may still fit for short‑term recovery.
A rich source of EPA and DHA omega-3 fatty acids, commonly used to support cardiovascular health and reduce inflammation.
Omega-3 fatty acids — specifically EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) — are polyunsaturated fats that the human body cannot synthesize de novo. They must be obtained from dietary sources, primarily fatty fish (salmon, mackerel, sardines, anchovies), shellfish, and marine algae. EPA and DHA serve as structural components of cell membranes throughout the body, with particularly high concentrations in the brain (DHA comprises roughly 40% of polyunsaturated fatty acids in the brain) and retina. Beyond structural roles, they are precursors to specialized pro-resolving mediators (SPMs) — resolvins, protectins, and maresins — that actively resolve inflammation rather than simply suppressing it. The evidence base for omega-3 supplementation is extensive. Large-scale trials and meta-analyses support benefits for cardiovascular health (triglyceride reduction, modest blood pressure lowering), inflammatory conditions, mood disorders, and cognitive maintenance. The American Heart Association recommends at least two servings of fatty fish per week, and higher-dose EPA supplementation has been shown to reduce cardiovascular events in the REDUCE-IT trial.
A bright yellow spice derived from the Curcuma longa plant, widely used in Ayurvedic and traditional medicine for its anti-inflammatory properties.
Osteoarthritis (OA) is the most common arthritis, driven by age, mechanical loading, prior injury, obesity, and genetics. It features progressive cartilage loss, subchondral bone changes, synovial activation, and periarticular muscle weakness. Patients typically report activity-related joint pain, stiffness (often <30 minutes in the morning), reduced function, and sometimes swelling or crepitus. Knees, hips, hands, and spine are most affected. Diagnosis is clinical, supported by radiographs showing joint-space narrowing, osteophytes, and sclerosis; MRI is rarely required for routine care. Western management prioritizes nonpharmacologic strategies with the strongest, most consistent benefits across guidelines: education, exercise therapy (aerobic, strengthening, neuromuscular/balance), and weight reduction for those with overweight/obesity. Topical NSAIDs are recommended as first-line pharmacologic therapy for knee and hand OA, with oral NSAIDs used when needed and appropriate. Acetaminophen has diminishing evidence of benefit. Duloxetine can help chronic OA pain, particularly knee OA. Intra-articular corticosteroid injections offer short-term relief; hyaluronic acid remains controversial with mixed evidence. Platelet-rich plasma (PRP) injections are emerging but heterogeneous and not yet guideline-endorsed broadly. Joint replacement is highly effective for end-stage disease. Eastern and traditional approaches conceptualize OA differently but often converge on movement-based and symptom-relieving therapies. In Traditional Chinese Medicine (TCM), OA commonly maps to Bi syndrome (painful obstruction) with patterns such as wind-cold-damp Bi, blood stasis, and kidney (shen) deficiency. Treatment may include acupuncture (including electroacupuncture and warm-needle techniques), moxibustion, topical herbal liniments (e.g., capsicum), tuina/manual therapy, and herbal formulas (e.g., Du Huo Ji Sheng Tang). Acupuncture for knee OA is among the best-studied TCM applications,
Rheumatoid arthritis (RA) is a chronic, systemic, autoimmune synovitis that, without timely control, leads to pain, progressive joint damage, disability, and increased cardiovascular risk. Western medicine defines RA by characteristic clinical patterns, serologic autoantibodies, and inflammatory markers, and prioritizes early, aggressive disease modification using a treat‑to‑target strategy. This approach, guided by rigorous randomized trials and international guidelines, has transformed outcomes—many patients can now achieve low disease activity or remission and preserve function. Diagnosis in Western practice uses ACR/EULAR classification criteria that integrate joint involvement, rheumatoid factor (RF) and anti‑cyclic citrullinated peptide (anti‑CCP) antibodies, acute‑phase reactants (ESR/CRP), and symptom duration. Imaging (ultrasound/MRI) can detect subclinical synovitis and erosions early. Management begins promptly—ideally within weeks of symptom onset—because early window therapy improves long‑term trajectories. First‑line conventional synthetic disease‑modifying antirheumatic drugs (csDMARDs) include methotrexate (anchor), sulfasalazine, hydroxychloroquine, and leflunomide. If targets (remission/low disease activity) are not met, biologic DMARDs (e.g., TNF, IL‑6, T‑cell costimulation, anti‑CD20) or targeted synthetic JAK inhibitors are added or substituted, with iterative monitoring every 1–3 months and shared decision‑making. Short glucocorticoid courses are sometimes used as a bridge, while NSAIDs treat pain but do not alter disease course. Safety monitoring, vaccination, infection screening, and comorbidity risk reduction (e.g., cardiovascular prevention, bone health, smoking cessation, exercise, rehabilitation) are integral. Eastern and traditional systems conceptualize RA differently but share aims of reducing pain, swelling, and functional limitations while preventing chronic deterioration. Traditional Chinese Medicine (TCM) frames RA within “Bi” (B
Arthritis (an umbrella term that includes inflammatory types such as rheumatoid arthritis and non‑inflammatory types such as osteoarthritis) and osteoporosis frequently intersect in mid‑ to late‑li...
Psoriasis is a chronic, immune-mediated skin disease affecting roughly 2–3% of the population. Psoriatic arthritis (PsA) is an inflammatory arthropathy that occurs in a substantial subset of people...
